ADCYAP1 and central nervous system disorder: The impact of PACAP on neurite number and growth, facilitated by actin polymerization, suggests potential treatments for neurologically derived degenerative diseases [41,42], for central nervous system disorders [43,44,45,46], severe head injuries [47], and regenerative medicine [87].